Apogee Therapeutics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
Apogee Therapeutics, Inc. (APGE) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $650.00 thousand as of 2022-06-30, per its 10-Q filed 2023-08-28.
Discontinued › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2023-08-28
- 2022-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $650.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value |
|---|---|
| 2022-06-30 | $650.00K 10-Q · filed 2023-08-28 |